EFG International AG Makes New Investment in Xylem Inc. $XYL

EFG International AG bought a new stake in Xylem Inc. (NYSE:XYL – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 7,926 shares of the industrial products company’s stock, valued at approximately $937,000.

A number of other hedge funds also recently modified their holdings of XYL. Callahan Advisors LLC bought a new stake in Xylem in the fourth quarter valued at approximately $1,721,000. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Xylem by 2,309.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after acquiring an additional 413,904 shares during the last quarter. Abacus Wealth Partners LLC bought a new stake in Xylem in the 4th quarter valued at $1,663,000. Norges Bank bought a new stake in Xylem in the 4th quarter valued at $361,012,000. Finally, MUFG Securities EMEA plc lifted its holdings in Xylem by 608.1% during the 4th quarter. MUFG Securities EMEA plc now owns 32,990 shares of the industrial products company’s stock valued at $4,493,000 after purchasing an additional 28,331 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Get Xylem alerts:

Xylem Trading Up 0.6%

Shares of NYSE:XYL opened at $113.51 on Thursday. The business’s 50 day simple moving average is $118.18 and its 200 day simple moving average is $119.13. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.61 and a quick ratio of 1.24. The company has a market capitalization of $26.50 billion, a P/E ratio of 27.03, a P/E/G ratio of 1.66 and a beta of 1.02.

Xylem (NYSE:XYL – Get Free Report) last released its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.12. The firm had revenue of $2.34 billion during the quarter, compared to analysts’ expectations of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The company’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.26 earnings per share. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, research analysts anticipate that Xylem Inc. will post 5.66 EPS for the current fiscal year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th will be given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date is Thursday, August 27th. Xylem’s payout ratio is currently 40.95%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on XYL shares. Royal Bank Of Canada upped their price objective on shares of Xylem from $159.00 to $164.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. Oppenheimer reduced their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. Mizuho increased their price target on shares of Xylem from $124.00 to $130.00 and gave the company a “neutral” rating in a report on Wednesday, July 29th. Weiss Ratings restated a “hold (c)” rating on shares of Xylem in a report on Wednesday, August 5th. Finally, Barclays upped their target price on Xylem from $154.00 to $159.00 and gave the company an “overweight” rating in a research report on Wednesday, July 29th. Nine research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

View Our Latest Analysis on Xylem

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

• Five stocks we like better than Xylem
• Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
• Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
• Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
• Can Tesla’s Flying Roadster Distract From Its Real Risks?

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.